Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.5M Buy
1,061,602
+306,285
+41% +$6.81M 0.01% 1089
2025
Q4
$14.5M Sell
755,317
-151,060
-17% -$3.18M ﹤0.01% 1345
2025
Q3
$21.8M Buy
906,377
+306,324
+51% +$7.16M 0.01% 1097
2025
Q2
$11.7M Buy
600,053
+326,225
+119% +$4.82M ﹤0.01% 1418
2025
Q1
$3.52M Sell
273,828
-56
-0% -$900 ﹤0.01% 2090
2024
Q4
$4.72M Sell
273,884
-71,394
-21% -$1.43M ﹤0.01% 2011
2024
Q3
$7.79M Sell
345,278
-6,100
-2% -$140K ﹤0.01% 1756
2024
Q2
$8.68M Sell
351,378
-145,565
-29% -$4.13M ﹤0.01% 1673
2024
Q1
$16.4M Sell
496,943
-390,476
-44% -$13.3M ﹤0.01% 1304
2023
Q4
$32.3M Buy
887,419
+65,909
+8% +$2.26M 0.01% 851
2023
Q3
$30.1M Buy
821,510
+563,549
+218% +$22.5M 0.01% 800
2023
Q2
$9.89M Buy
257,961
+3,067
+1% +$113K ﹤0.01% 1519
2023
Q1
$10.4M Sell
254,894
-606,429
-70% -$25.3M ﹤0.01% 1455
2022
Q4
$29.9M Sell
861,323
-46,258
-5% -$1.62M 0.01% 800
2022
Q3
$25.2M Sell
907,581
-108,884
-11% -$3.53M 0.01% 876
2022
Q2
$30.1M Sell
1,016,465
-154,230
-13% -$5.18M 0.01% 780
2022
Q1
$44.1M Sell
1,170,695
-1,979,669
-63% -$85M 0.01% 696
2021
Q4
$151M Sell
3,150,364
-52,328
-2% -$2.35M 0.04% 340
2021
Q3
$133M Sell
3,202,692
-226,589
-7% -$9.03M 0.04% 369
2021
Q2
$155M Buy
3,429,281
+256,688
+8% +$12M 0.05% 345
2021
Q1
$140M Sell
3,172,593
-1,168,405
-27% -$44.1M 0.04% 361
2020
Q4
$151M Buy
4,340,998
+3,321,103
+326% +$93.6M 0.05% 329
2020
Q3
$17.7M Sell
1,019,895
-126,867
-11% -$2.21M 0.01% 1134
2020
Q2
$18.8M Buy
1,146,762
+35,585
+3% +$541K 0.01% 1083
2020
Q1
$10.1M Buy
1,111,177
+524,084
+89% +$10.6M ﹤0.01% 1286
2019
Q4
$12.5M Buy
587,093
+239,188
+69% +$5.31M ﹤0.01% 1450
2019
Q3
$7.99M Sell
347,905
-6,362
-2% -$145K ﹤0.01% 1700
2019
Q2
$8.6M Buy
+354,267
New +$7.29M ﹤0.01% 1696

Other funds holding ADNT

Nuveen's ADNT Position: Q1 2026 in Review

Nuveen increased its Adient (ADNT) stake by 41% in Q1 2026, buying an estimated $6.81M and bringing the position to 1,061,602 shares worth $21.5M. The position accounts for 0.01% of the portfolio, ranked #1089.

Nuveen first reported a position in ADNT in Q2 2019 and has held it in 28 quarters since. The position peaked at $155M in Q2 2021. 287 funds tracked by Wall St. Rank hold ADNT as of Q1 2026.

  • Nuveen held 1,061,602 shares of Adient worth $21.5M as of Q1 2026.
  • Nuveen bought 306,285 Adient shares in Q1 2026, an estimated $6.81M.
  • Adient made up 0.01% of Nuveen's portfolio in Q1 2026, its #1089 holding.
  • Nuveen first reported a position in Adient in Q2 2019 and has held it in 28 quarters since.
  • Nuveen's Adient position peaked at $155M in Q2 2021.
  • 287 funds tracked by Wall St. Rank held Adient as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.